Aerovate Therapeutics, Inc. (AVTE) Ownership

$2.70

north_east
$0.02 (0.75%)
Day's range
$2.68
Day's range
$2.71

Aerovate Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 02/14/2025 9.19 M $24.36 M   0.00% 31.85%
SOFINNOVA INVESTMENTS, INC. 02/14/2025 3.76 M $9.96 M   0.00% 13.02%
TCG CROSSOVER MANAGEMENT, LLC 02/14/2025 2.24 M $5.94 M   0.00% 7.76%
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC 02/06/2025 1.80 M $4.77 M   0.00% 6.23%
BRAIDWELL LP 02/14/2025 1.44 M $3.82 M   100.00% 4.99%
LOGOS GLOBAL MANAGEMENT LP 02/14/2025 1.40 M $3.71 M   100.00% 4.85%
VANGUARD GROUP INC 02/11/2025 1.00 M $2.66 M   -13.02% 3.47%
BLACKROCK FUNDING, INC. /DE 02/07/2025 975,423 $2.58 M   2.28% 3.38%
ADAR1 CAPITAL MANAGEMENT, LLC 02/13/2025 928,016 $2.46 M   720.71% 3.22%
ALLOSTERY INVESTMENTS LP 02/14/2025 850,684 $2.25 M   100.00% 2.95%
AFFINITY ASSET ADVISORS, LLC 02/13/2025 800,000 $2.12 M   33.33% 2.77%
JEFFERIES FINANCIAL GROUP INC. 02/27/2025 600,000 $1.59 M   100.00% 2.08%
BLACKSTONE INC. 02/14/2025 499,566 $1.32 M   100.00% 1.73%
NANTAHALA CAPITAL MANAGEMENT, LLC 02/14/2025 482,928 $1.28 M   100.00% 1.67%
STATE STREET CORP 02/14/2025 375,360 $994,704   2.15% 1.30%
GOLDMAN SACHS GROUP INC 02/11/2025 314,369 $833,078   95.25% 1.09%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 294,657 $780,983   0.95% 1.02%
TWO SIGMA INVESTMENTS, LP 02/14/2025 226,121 $599,221   -27.78% 0.78%
DELTEC ASSET MANAGEMENT LLC 01/27/2025 194,124 $514,429   100.00% 0.67%
02/14/2025 191,600 $507,740   100.00% 0.66%
TWO SIGMA ADVISERS, LP 02/14/2025 153,600 $407,040   38.50% 0.53%
GROUP ONE TRADING, L.P. 02/14/2025 139,844 $370,587   1,310.14% 0.48%
PRELUDE CAPITAL MANAGEMENT, LLC 02/14/2025 109,442 $290,021   100.00% 0.38%
VERITION FUND MANAGEMENT LLC 02/14/2025 94,635 $250,783   -5.19% 0.33%
ACADIAN ASSET MANAGEMENT LLC 02/11/2025 85,793 $227,000   -76.13% 0.30%
VAZIRANI ASSET MANAGEMENT LLC 02/14/2025 75,000 $198,750   100.00% 0.26%
FNY INVESTMENT ADVISERS, LLC 01/13/2025 75,000 $198,000   100.00% 0.26%
ALLIANCEBERNSTEIN L.P. 02/12/2025 69,910 $185,262   0.00% 0.24%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 68,200 $180,730   1.49% 0.24%
JPMORGAN CHASE & CO 02/12/2025 67,165 $177,987   1,021.10% 0.23%
MILLENNIUM MANAGEMENT LLC 02/14/2025 65,698 $174,100   -66.59% 0.23%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/14/2025 60,000 $159,000   100.00% 0.21%
BANK OF MONTREAL /CAN/ 02/13/2025 59,097 $156,607   86.76% 0.20%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 57,752 $153,043   100.00% 0.20%
BNP PARIBAS ARBITRAGE, SNC 02/14/2025 54,688 $144,923   100.00% 0.19%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 52,700 $139,655   105.06% 0.18%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 44,600 $118,190   149.16% 0.15%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 40,047 $106,124   0.00% 0.14%
BANK OF NEW YORK MELLON CORP 02/04/2025 37,674 $99,836   -9.14% 0.13%
SCOTIA CAPITAL INC. 02/13/2025 37,210 $98,606   100.00% 0.13%
CI PRIVATE WEALTH, LLC 02/10/2025 36,897 $97,777   100.00% 0.13%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 29,351 $77,780   0.00% 0.10%
HARVEST INVESTMENT SERVICES, LLC 02/14/2025 23,919 $63,385   100.00% 0.08%
XTX TOPCO LTD 02/13/2025 23,745 $62,924   100.00% 0.08%
BARCLAYS PLC 02/13/2025 21,435 $57,000   12.98% 0.07%
SQUAREPOINT OPS LLC 02/14/2025 19,564 $51,845   100.00% 0.07%
AQR CAPITAL MANAGEMENT LLC 02/14/2025 18,854 $49,964   -58.42% 0.07%
SIMPLEX TRADING, LLC 02/11/2025 18,779 $49,000   273.93% 0.07%
CITIGROUP INC 02/12/2025 16,216 $42,973   -93.05% 0.06%
RUSSELL INVESTMENTS GROUP, LTD. 02/13/2025 15,184 $40,238   110.68% 0.05%

Aerovate Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 99 institutional investors and hedge funds held shares of Aerovate Therapeutics, Inc.. The most heavily invested institutionals were:

RA CAPITAL MANAGEMENT, L.P.: 9.19 M

Sofinnova Investments, Inc.: 3.76 M

TCG Crossover Management, LLC: 2.24 M

Atlas Venture Life Science Advisors, LLC: 1.8 M

BRAIDWELL LP: 1.44 M

Logos Global Management LP: 1.4 M

104.51% of Aerovate Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 31.32 M shares in the last 24 months. This purchase volume represents approximately $84.56 M in transactions.